Yamamoto Hideya, Kitagawa Toshiro, Kihara Yasuki
Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences.
J Atheroscler Thromb. 2014;21(11):1101-8. doi: 10.5551/jat.26427. Epub 2014 Sep 26.
Coronary artery calcification (CAC) is a well-established surrogate marker of the total burden of coronary atherosclerosis. The CAC score, as measured on coronary computed tomography (CT), is associated with the prevalence of coronary artery disease (CAD) as well as cardiovascular morbidity and mortality. The CAC score is used to reclassify coronary risks in asymptomatic individuals with intermediate risks. However, there are few clinical data regarding the usefulness of the CAC score for identifying high-risk Japanese patients. In this review article, we describe our previous studies of the prognostic value of the CAC score in patients with proven or suspected CAD. In addition, we reanalyzed our previous data for 723 patients with suspected CAD and found both all-cause and cardiovascular disease mortality to be significantly higher among the patients with a CAC score of ≥100 than among those with a CAC score of <100. Several studies from Japan have also shown that the CAC score is associated with the prevalence of obstructive CAD, as demonstrated on invasive coronary angiography or stress myocardial perfusion imaging. Furthermore, the CAC score provides useful information for performing coronary CT angiography, as asymptomatic patients without CAC are expected to have favorable outcomes. In contrast, the diagnostic accuracy is decreased in patients with a high CAC score (>400 or 600). In conclusion, the CAC score may have useful clinical applications in symptomatic and asymptomatic Japanese individuals. However, further studies are required to evaluate the prognostic value of this parameter for predicting cardiovascular morbidity and mortality in population-based analyses of asymptomatic Japanese subjects.
冠状动脉钙化(CAC)是冠状动脉粥样硬化总负担的一个公认替代标志物。通过冠状动脉计算机断层扫描(CT)测量的CAC评分与冠状动脉疾病(CAD)的患病率以及心血管发病率和死亡率相关。CAC评分用于对具有中等风险的无症状个体重新分类冠状动脉风险。然而,关于CAC评分对识别高危日本患者的有用性的临床数据很少。在这篇综述文章中,我们描述了我们之前对已证实或疑似CAD患者的CAC评分预后价值的研究。此外,我们重新分析了之前723例疑似CAD患者的数据,发现CAC评分≥100的患者全因死亡率和心血管疾病死亡率均显著高于CAC评分<100的患者。来自日本的几项研究也表明,CAC评分与侵入性冠状动脉造影或负荷心肌灌注成像所示的阻塞性CAD患病率相关。此外,CAC评分为进行冠状动脉CT血管造影提供了有用信息,因为无CAC的无症状患者预期有良好预后。相比之下,CAC评分高(>400或600)的患者诊断准确性会降低。总之,CAC评分可能在有症状和无症状的日本个体中有有用的临床应用。然而,需要进一步研究来评估该参数在基于人群的无症状日本受试者分析中预测心血管发病率和死亡率的预后价值。